Kalvista Pharmaceuticals Inc. (KALV)

Hedge Fund Popularity

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Vivo Capital

Albert Cha And Frank Kung

1,533,559 $22,605 1.55%
2.
Birchview Capital

Matthew Strobeck

40,000 $590 0.42%
3.
Ikarian Capital

Neil Shahrestani

39,730 $586 +9% 0.07%
4. 16,800 $248 -26% 0%
5. 0 $0 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$17.34 47,431 Director 1,138,179 2020-10-30 Filing
$17.17 68,255 Director 1,090,748 2020-10-30 Filing
$11.87 7,962 Director 10,000 2019-09-27 Filing
$11.90 2,038 Director 2,038 2019-09-26 Filing
$17.13 5,137 Director 124,566 2019-07-29 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$17.07 10,000 Officer, Director 114,670 2022-03-09 Filing
$18.07 6,000 Officer 2,234 2021-11-01 Filing
$18.07 5,000 Officer 32,969 2021-11-01 Filing
$17.18 10,000 Officer, Director 124,670 2021-10-01 Filing
$20.52 5,000 Officer 37,969 2021-08-02 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 1,544,027 $22,757 0%
2. 1,239,731 $18,273 0%
3. 1,166,652 $17,196 0%
4. 825,350 $12,166 0%
5. 484,103 $7,136 0%
News See All